AZZI, ALBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.169
EU - Europa 5.279
AS - Asia 2.999
SA - Sud America 371
AF - Africa 92
OC - Oceania 92
Continente sconosciuto - Info sul continente non disponibili 64
Totale 18.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.073
RU - Federazione Russa 1.719
IT - Italia 978
SG - Singapore 894
PL - Polonia 805
CN - Cina 647
HK - Hong Kong 501
SE - Svezia 459
IE - Irlanda 456
VN - Vietnam 307
BR - Brasile 278
KR - Corea 257
UA - Ucraina 208
DE - Germania 188
FI - Finlandia 147
FR - Francia 128
IN - India 104
GB - Regno Unito 90
AU - Australia 89
JO - Giordania 72
CA - Canada 59
CI - Costa d'Avorio 38
BD - Bangladesh 30
TR - Turchia 30
AR - Argentina 28
JP - Giappone 27
IQ - Iraq 23
CH - Svizzera 20
MX - Messico 20
NG - Nigeria 18
CO - Colombia 17
ID - Indonesia 17
NL - Olanda 17
AT - Austria 16
EC - Ecuador 14
PH - Filippine 12
BE - Belgio 10
PY - Paraguay 10
SA - Arabia Saudita 10
VE - Venezuela 10
PK - Pakistan 9
ZA - Sudafrica 8
ES - Italia 7
KZ - Kazakistan 6
MA - Marocco 6
OM - Oman 6
TW - Taiwan 6
AZ - Azerbaigian 5
EG - Egitto 5
SC - Seychelles 5
UY - Uruguay 5
KG - Kirghizistan 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BY - Bielorussia 3
CL - Cile 3
CZ - Repubblica Ceca 3
EE - Estonia 3
GT - Guatemala 3
HR - Croazia 3
IL - Israele 3
KE - Kenya 3
LK - Sri Lanka 3
MU - Mauritius 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SM - San Marino 3
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
IR - Iran 2
MK - Macedonia 2
NP - Nepal 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TJ - Tagikistan 2
A1 - Anonimo 1
AM - Armenia 1
AO - Angola 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GE - Georgia 1
LB - Libano 1
NI - Nicaragua 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TC - Turks e Caicos 1
Totale 18.004
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.925
Warsaw 804
Ashburn 725
Fairfield 702
Singapore 657
Chandler 513
Dublin 455
Hong Kong 402
San Jose 359
Woodbridge 336
Jacksonville 324
Cambridge 292
Houston 258
Seattle 257
Seoul 255
Milan 212
Wilmington 202
Beijing 186
Council Bluffs 147
The Dalles 133
Princeton 126
Ann Arbor 120
Buffalo 106
Rome 104
Dallas 96
Lauterbourg 95
Ho Chi Minh City 94
Melbourne 86
Florence 82
Mumbai 79
Boston 77
Kent 77
Los Angeles 75
Hanoi 69
Hefei 69
Medford 66
Boardman 59
Altamura 48
Lawrence 46
Munich 46
Moscow 43
Phoenix 39
Abidjan 38
San Diego 34
Shanghai 32
Norwalk 29
New York 28
Redondo Beach 28
São Paulo 28
Atlanta 25
Naples 23
Tokyo 23
Bari 21
Helsinki 20
Izmir 20
Toronto 20
Figino 19
Da Nang 18
Abuja 17
Brooklyn 17
London 17
Turin 16
Wayne 16
Vienna 15
Tianjin 14
Brescia 13
Columbus 13
Frankfurt am Main 13
Hillsboro 12
Rio de Janeiro 12
Andover 10
Bologna 10
Chicago 10
Guangzhou 10
Palermo 10
Saint Petersburg 10
Turku 10
Baghdad 9
Orem 9
Brussels 8
Clifton 8
Denver 8
Dong Ket 8
Falls Church 8
Jakarta 8
Padua 8
Catania 7
Parma 7
Sesto Fiorentino 7
Stockholm 7
Verona 7
Amsterdam 6
Belo Horizonte 6
Brasília 6
Frankfurt Am Main 6
Genoa 6
Haiphong 6
Hải Dương 6
Laurel 6
Montreal 6
Totale 11.660
Salva come PNG Salva come JPEG
Nome #
Molecular markers of influenza B lineages and clades 502
Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. 371
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 360
H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support 358
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals 344
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 339
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). 308
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center 278
Artrite reumatoide e parvovirus B19: osservazioni preliminari 260
A real-time reverse transcriptase-polymer chain reaction to evaluate natural history of viral shedding in outpatient children and adolescents with pandemic 2009 influenza A(H1N1). 224
Human herpesviruses respiratory infections in patients with acute respiratory distress (ARDS) 219
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 214
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 213
CONFUTAZIONE DI RECENTI IPOTESI ETIOLOGICHE PER LA PITIRIASI ROSEA DI GIBERT. 203
Tissue persistence of parvovirus B19 genotypes in asymptomatic persons 202
HA222 polymorphism in Influenza A(H1N1) 2009 isolates from Intensive Care Units and ambulatory patients during three influenza seasons. 199
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. 197
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. 192
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 192
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 191
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 190
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 190
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 189
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. 187
Human parvovirus B19 (B19V) infection in systemic sclerosis patients. 187
PRESENCE OF TT VIRUS (TTV) DNA IN BONE MARROW CELLS FROM HAEMATOLOGIC PATIENTS 185
Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products. 183
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy. 177
Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. 176
A FRET based melting curve analysis to detect nucleotide variations in HA receptor-binding site of H5N1 virus. 176
BK virus regulatory region sequence deletions in a case of human polyomavirus associated nephropathy (PVAN) after kidney transplantation. 175
High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses. 175
Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. 173
Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. 172
Human parvovirus B19 infection in bone marrow transplantation patients 172
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 166
Human herpesvirus 8 (HHV-8) DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy blood donors. 162
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. 161
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 159
aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia 158
Polyomavirus BK-specific immunity after kidney transplantation. 157
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients 156
Lymphocytopenia as a marker for pandemic influenza A/H1N1 2009 virus infection in children. 156
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by nested polymerase chain reaction 156
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. 153
Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. 152
No association between human parvovirus B19 infection and Sjogren's syndrome. 150
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. 149
Cryptococcus infection in immunodepressed subjects 147
Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. 146
Cryptococcose disséminée chez le chat. 145
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 145
Cryptococcose chez le chien: deux cas cliniques. 143
Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. 141
Human parvovirus B19 infection within a family and risk for pregnant women 140
TT virus contaminates first-generation recombinant factor VIII concentrates. 139
Cytopenia caused by parvovirus in adult ALL patient 139
Inchiesta sulla diffusione della criptococcosi nei portatori di HIV in Italia 139
Detection of B19 parvovirus infections by dot-blot hybridization assay using a digoxigenin-labelled probe 138
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated Factor VIII concentrate 137
Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera 136
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 134
INTRAUTERINE PARVOVIRUS B19 INFECTION: EARLY PRENATAL DIAGNOSIS IS POSSIBLE. 133
BKV e HPV nel sarcoma di Kaposi (KS) AIDS correlate 133
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. 132
Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis 132
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 131
Indagine epidemiologica sull'infezione da parvovirus B19 in diverse categorie 130
Polymerase chain reaction for synthesis of digoxigenin-labelled DNA probe: application to parvovirus B19 and to polyomavirus BK 129
Parvovirus B19 infection in cultured skin fibroblasts from systemic sclerosis patients: a comment on the article of Ray et al. 129
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. 128
In vitro and ex vivo detection of human polyomavirus JC microRNA 128
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients 128
Development of a Quantitative Competitive Polymerase Chain Reaction for Human Polyomavirus BK 127
Parvovirus B19 infection of bone marrow in systemic sclerosis patients 126
Parvovirus B19 and systemic sclerosis. 126
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 126
Isolation of influenza A(H3N2) virus with "O"-->"D" phase variation. 126
Multicentre Italian Study Group (MISG) for the standardisation of hepatitis C virus (HCV) PCR. 124
NO ASSOCIATION BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND SJÖGREN¿S SINDROME. 123
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy. 123
Use of denaturing gradient gel electrophoresis for human polyomavirus JC sequence analysis. 120
Packaging signals in the 5' coding region of influenza virus PA, PB1, and PB2 genes as potential target to develop oligonucleotide based antiviral molecole. 120
Unusual incidence of aplastic Anaemia due to B19 parvovirus infection in renal transplant recipients 120
BK and JC viruses 119
Sorveglianza delle infezioni fungine nelle leucemie acute. 118
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. 118
Severe aplastic anaemia due to B19 parvovirus infection in renal transpalnt recipient 117
The transfusion-associated transmission of parvovirus B19. 116
Parvovirus B19 and systemic sclerosis 116
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow tranplantation patients 115
Presence of TT virus DNA in bone marrow cells from hematologic patients. 112
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 110
Letter to Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated Factor VIII concentrate: the role of human B19 parvovirus 110
Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. 106
Parvovirus B19 infection in a patient with cutaneous vasculitis, arthralgia and paresthesia 105
First-generation recombinant factor VIII concentratesare free from viral contaminations? 103
Hemorrahagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia 103
Sonda marcata con digossigenina per la ricerca di BKV 103
Development of new antivirals against the influenza type A viruses based on small RNAs targeting the packaging signal of the polymarases gene coding region. 102
Totale 16.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022532 0 0 15 21 33 31 15 33 43 27 106 208
2022/20231.908 224 226 89 140 163 399 265 100 213 16 51 22
2023/2024617 37 84 123 23 34 32 24 94 9 33 83 41
2024/20254.923 168 551 311 717 1.436 900 61 272 201 74 148 84
2025/20264.485 571 626 351 240 547 164 596 207 257 229 101 596
2026/20271.147 159 646 342 0 0 0 0 0 0 0 0 0
Totale 18.066